Clotrimazole

ADVERTISEMENT

Identification

Molecular formula
C22H17ClN2S
CAS Number
23593-75-1
IUPAC Name
3-[(4-chlorophenyl)methyl]-2-[3-(1H-imidazol-5-yl)propyl]isothiourea
Molecular Weight
344.90g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2020g/cm3
Synonyms
clobenpropit
Interesting facts

Interesting Facts about 3-[(4-chlorophenyl)methyl]-2-[3-(1H-imidazol-5-yl)propyl]isothiourea

This compound, a member of the isothiourea family, boasts a complex structure that intertwines various functional groups, making it a subject of great interest in the realm of medicinal chemistry. Here are some noteworthy points:

  • Pharmacological Potential: Compounds like this one often exhibit a range of biological activities, including anti-inflammatory and antitumor properties. Research may unveil its potential in targeting specific diseases.
  • Molecular Diversity: The presence of the 1H-imidazol-5-yl moiety suggests intriguing interactions with biological targets, especially in enzyme inhibition or receptor modulation.
  • Bridge to Therapeutics: Isothioureas have been studied for their ability to act as enzyme inhibitors, which may lead to the development of new therapeutic agents in treating conditions such as cancer and diabetes.
  • Halogen Influence: The 4-chlorophenyl group exemplifies how halogen substitutions can significantly modify the pharmacokinetic properties of organic compounds, potentially increasing their bioavailability and interaction with target sites.
  • Synthetic Utility: The synthetic pathways leading to such compounds are of great interest, opening avenues for innovative chemical synthesis techniques that can yield structurally diverse derivatives.

In summary, the compound 3-[(4-chlorophenyl)methyl]-2-[3-(1H-imidazol-5-yl)propyl]isothiourea encompasses a rich tapestry of chemical properties and potential applications in the biomedical field. Its multifaceted structure not only holds promise for future research but also poses exciting questions in the study of structure-activity relationships.

ADVERTISEMENT